what the nih does is it gives money to university researchers. they develop new knowledge and then how biology works. producessometimes information. and sometimes they are encouraged by federal law to license those. that is not the only place where companies get their ideas. that is the first mile. run by the miles is companies. we fundnd way more then the nih. it can take 12 years to get a product to market. and more times, they fail. saying that is not how to we reimburse the companies brought the money they have spent? look at alzheimer's. alzheimer's is costing $250 billion a year now. our failure in finding a treatment for alzheimer's is 100%. our companies have spent billions of dollars to find a treatment for this terribly punishing, brutal disease that might only punishes the patients but their entire family. we failed every time. we suck it up, absorb losses and back at it trying to find new treatments for all slammers. if we kill that process, look at what we have lost in terms of reduce suffering. will chat with a few more colors befor

the nih is taxpayers. the nih is the single largest funder of medical research in the world. meanwhile, independent analyses show drug companies show more on advertising and marketing. why do drug companies chart so much? because they can. yes. drug companies should profit profit when they develop innovated drugs. we are way out of balance right now. family finances, health outcomes and our lives. i want to suggest three things that we can do to balance the risks. pricing power without taxpayer negotiations. extending their government drafting monopolies. mr. jordan mentioned any competitive a4 delay deals. we need to correct those. >> we need direct medicare price negotiations. our current system is not working. we paid 2-3 times what other countries pay for the exact same drugs. other countries negotiate, we should, too. inflation caps just pass out of the senate finance committee. bipartisan vote. other ways to restrain list prices. we also need to restructure along the lines. finally, we need more transparency. huge companies cut deals to determine how much patients pay.

in fact, the nih is the single largest funder of biomedical research in the world. and while independent analysis show that nine out of 10 drug companies spend more on advertising and marketing and they do on our and the . why do drug companies charge so much? because they can. drug companies should profit when they develop innovative drugs but we are out of balance right now and it's costing us in our family finances, our health outcomes and our lives. i want to suggest three things we can do to rebalance the actual risk of innovation with a fair price for patients. one, perform patent law, too, and the days of monopoly without taxpayer negotiations and forced transparency from drugmiddlemen . drug companies are abusing our system to extend their government granted monopolies and use a whole array of tactics, mister jordan mentioned rent abuses, anti-competitive days, evergreen, sham petitions. we need to correct those and there are bills moving through congress to do that. next, we need direct medicare price negotiations and we need to restructure medicare part d.

right nowconcerns because nih has given access of u.s. genomic data to for-profit companies in china. and these companies have ties to the chinese government. now this is not reciprocal. care we like to thank everybody is sharing data for the greater good and that's how i always believed that things were. case.at's not the in china they actually have a law. their data doesn't go outside of their boundaries. they don't share any of their data. they get our data that they don't share any data. new law there is a there that you can't even use any biomaterials from china unless there's a chinese collaborative organization involved. important toy understand what the national security risks are for sharing health data with china and other countries. it's important to understand what regulations we have in place for sharing genomic data. it's important for us to understand what payments we are making through cms. what payments are federal government is making to other countries to hold and handle our data. important fory cms and private companie

there are concerns right now because nih has given access to us genomic data before companies in china. and these companies have ties to the chinese government . now, this is not reciprocal. so in healthcare we like to think everybody's sharing data for the greater good. and that's how i believe that things were. but that's not the case. in fact, in china they have a law. doesn't go outsidetheir boundaries, they don'tshare any of their data . our data but they don't share any data . in fact, there's a new law there, you can't even use any biomaterial from china unless there's a tiny collaborative for anorganization involved . so it's really important to understand what the national security risks are sharing help data with china and other countries. it's important to understand what regulations we have in place for sharing our us human data. it's important for us to understand what payments we are making through cms, what payments are federal government and cms is making to other countries to hold and handle our data. and it's really important for cms and for private companies to consi

what the nih does is it gives money to university researchers.y develop new knowledge and then how biology works. producessometimes information. and sometimes they are encouraged by federal law to license those. that is not the only place where companies get their ideas. that is the first mile. run by the miles is companies. we fundnd way more then the nih. it can take 12 years to get a product to market. and more times, they fail. saying that is not how to we reimburse the companies brought the money they have spent? look at alzheimer's. alzheimer's is costing $250 billion a year now. our failure in finding a treatment for alzheimer's is 100%. our companies have spent billions of dollars to find a treatment for this terribly punishing, brutal disease that might only punishes the patients but their entire family. we failed every time. we suck it up, absorb losses and back at it trying to find new treatments for all slammers. if we kill that process, look at what we have lost in terms of reduce suffering. will chat with a few more colors before yo

there are concerned right now because nih's given access to u.s.ata to for-profit companies in china. .. are there other avenues we might want to be worried about and if we could talk about that for a bit as well. >> you guys can probably hear me we certainly see this all the time. does that were? all right. so one of the things that i mentioned was the potential ransomware attack. this is what essentially you have a form of nowhere that it puts all of the data in the health system and makes it inaccessible to anyone using those systems effectively shutting down anything that runs on any form of data. there are still some things that hospitals probably should but they don't do that means it can be huge because suddenly you've lost access to critical systems. another big concern that has been proven time and time again is we have done theoretical research and we don't know if potential device related hacking you can imagine insulin pump certain implanted defibrillator could readily be call provides a good he used the fully given the function of thos

the nih, the national cancer institute, that funds innovation with the private sector, so it's really been a public-private partnership. >> ok. much of current concern about u.s. health care focuses on high drug costs. is this a new phenomena and or does it have deeper historical roots? a new phenomenon. wheren interesting area prescription drugs in particular draw a system of drugs dependent on the use of patent protection to encourage innovation and the developed insystem the early world war ii, 1950's, but it really set up a system incentivized innovation, but protected it in a way that made for a very high cost in terms of prescription drugs. the cost of prescription drugs thealready an issue by 1950's. price were finding the very hard to bear and of course, medicare did not cover prescription drug costs until very, very recently. this is been an issue for a length of time. when people talk about federal involvement in health care, they usually think of medicare and medicaid, but veterans affairs also offers government-funded health care. how did it arise in what lessons can offer

the nih, thank god is well-funded by the congress. basiconey goes to research. not trying to create a drug but find out why a seal works in this way. or how the genetics of this system worked. a startup company might lease or intellectual property and the mr. to develop and process. it could take 12 years. .bout $2 billion they take the data to the clinical trials. it, theya approves said price. whether it is in medicare, they negotiate the prices. what happens is the negotiating with a pharmaceutical benefits -- the idea of a pbm was a good initially. there are three companies that make this duck. i represent 50 million people. from insurance companies or employers. whoever gives me the best price, we are going to take that drug and give to those patients. now they say three companies, i am going to buy one of your drugs. who will give me the biggest rebate to put in my pocket? coachesult of that, the have to raise their list places to give the pbm. the patient does not get the business. the patient and the paying on the list price. is time to do away with pdfs

nih got a lot of the. i was on. and off he just got. ready back at the last line explains it's as busy as any bricks and mortar hospital. you can get a year. even if i. run the trains head shift has lived and worked on board for a staggering 26. 4 years let alone to yourself to look at the. it didn't they don't buy you the doctor to go by that they were tired of the need. for money but no hard feelings. or cooperating are. coming out of you know your comfort zone of operating in the. hospital or telling anyone because it is our situation you are are not many things but we. are sort of people. ringback can't imagine how people here are feeling tired or anxious and in a minute they can walk through that door and hop on an operating table or said. that could change their mind. when i'm doing a one because there's only one guess for me. i don't think i want anything else other than that but you can look it's. going to having to start from everyone it will go to a lot of my hundreds of my brain and my heart what is with that picture. lost bu

to act.und the nih so we can cure alzheimer's, cure cancer, take diseases head-on. i would make sure we have more home health aides so those individuals who want aid in place, want to stay at homes with their families, have the resources they need. thank you so much. i want to allow student to be financed at the lowest rate. and we can have debt-free college in exchange for public service. >> thank you. [indiscernible] >> former colorado governor john hickenlooper was among the presidential candidates who spoke at the iowa state fair. he always took questions from viewers afterward. >> thank you, rachel. thank you for sitting out here in the hot sun. i have been out here for the last few hours. my job is to give you the reasons you will take home and tell your family and friends why that guy with the funny last name is the right guy for our next president.

to act.und the nih so we can cure alzheimer's, cure cancer, take diseases head-on. i would make sure we have more home health aides so those individuals who want aid in place, want to stay at homes with their families, have the resources they need. thank you so much. i want to allow student to be financed at the lowest rate. and we can have debt-free college in exchange for public service. >> thank you. [indiscernible]

to act.und the nih so we can cure alzheimer's, cure cancer, take diseases head-on. i would make sure we have more home health aides so those individuals who want aid in place, want to stay at homes with their families, have the resources they need. thank you so much. i want to allow student to be financed at the lowest rate. and we can have debt-free college in exchange for public service. >> thank you. [indiscernible] campaign 2020 coverage continues tuesday with democratic presidential candidate mayor pete buttigieg from south bend, indiana speaking at voters at the iowa state fair. campaign 2020, watch our live coverage of the presidential candidates on the campaign trail and makeup euro mind. c-span's campaign 2020, your unfiltered view of politics. >> c-span's "washington journal" live every day with news and policy issues that impact you. we willp this morning, talk about prescription drug prices with patients for affordable drugs founder, david mitchell, and washington free vegan on the federal response to recent gun violence. campaignscussion of 2020 and ios

nih, and they're going to hopefully give hope to the people who have been contracting this deadly disease. when we were there in the zone a shortish time ago, one of the biggest issues they this had is convincing people to get behind it. they felt ebola was a death sentence. if they can get people out from this conflict ridden area of the congo, that it actually is good for you to come because you may be cured, this could have a major impact on this and future outbreaks. >> fantastic news for this deadly disease. david mckenzie, thank you very much. >>> just in time for back to school. a new subscription service for your kids' shoes. cnn business has the details coming up. al-b just cleans bett it's the one inspired by dentists... with the round brush head. oral-b's gentle rounded brush head removes more plaque along the gumline... for cleaner teeth and healthier gums. oral-b. brush like a pro. it's something we take personally, and believe in passionately. it's the idea that if our mothers were diagnosed with cancer, how would we want them to be treated? that's exactly how we care for yo

do you know bob springsteen at the nih? [laughter] thank you. was that genuine? or facetious?ld tell me we don't even know what to tell you what to eat or not eat or what specific things power or don't power your immune system we are not at that specificity yet. but there are things today that will boost the immune system they are extraordinary and dangerous. the reason jason returned from the grave nine toes in the grave because he took a drug that unleashed the immune system. here has cancer traditionally is fought we try to fight the pathogen itself the mutation itself by pouring toxins into the body, chemotherapy is aptly named talking about throwing agent orange into your body. i hate saying that because i know people who have gone through it it's a delicate way to describe a horrible process. but with the way we are trying to find one - - fight cance cancer, can we boost the immune system? the way we think about it no now, rather than attacking the tumor with toxins, could we cause the immune system to do what it was built to do in the first place? can we take the brakes

there's no magic wand, i we need i think rather desperately to have the cdc and nih to conduct researchcan make america safer from guns. and we certainly are not going to repeal the second amendment, but the second amendment doesn't say you have to act stupid. you can have common sense, and that applies to all three branches of government. >> let me ask you quickly before we move on, based on everything you just said, one of the biggest factors frankly has been the very strong lobby of the nra we have seen and we have seen it dominate the conversation. the fact the president had a conversation with the head of the florida who told him this week even when it comes to background checks, the president's support for that could really harm his base. are we at a point in time where you think white house and congress can start to ignore the influence of the nra and listen to their constituents? >> well, i don't think congress are going ignore the members of nra. nra leaders don't always reflect the leaders. they go to more extreme positions. many times they're worried about the competition, so

the nih is aware of it. as far as you understand it, how is the industry reacting?ing that juul there on studies on this. and they have to submit their own study to the fda by next year. they are looking at a lot of this because they have to weigh the risks and the benefit and prove to the fda that these products are more beneficial than they are harmful. i think we will see some of their research which i imagine will attempt to contradict smooth is coming out over several months. and be included in what they sent to the fda. emily: more to come. thank you so much for joining us. fitbit is pushing beyond hardware and into services. the cofounder and ceo tells us how the news description model will help the company take on a petition from apple and amazon. this is bloomberg. ♪ emily: the u.s. justice forrtment is opposing a bid internet cable between u.s. and hong kong. it is intended to bring faster connections for investors on both sides of the pacific. so far, construction has been conducted under a tech desk every permit. fitbit has struggled to beat in againstt

some of the nih sponsored studies in china, that is my only experience working with academia in china. if you work with universities, conform toys have to the nih requirements on the informed consent as well as human subject training. not by initiated collaboration with the u.s. government, then those are the areas -- those will be the gray areas. >> the final question to any and all of you, we talk a lot about production, obviously a production of pharmaceuticals, which is critically important, but also r&d is really important for the next generation, particularly chemotherapy. a lot of it is keep yourself alive until the next drug comes online. is the u.s. losing our leading research scientists to companies either operating here or companies that are in china? >> i can address that somewhat. i don't think i would go so far as to say we are losing our leading scientists. states isn the united heavily dependent on an international researcher community and china certainly does have programs to entice top to relocatesonnel to china, giving them large startup packages and whatnot. target

obama when i was majority leader of the senate was a bill called 21st century [inaudible] bill with nih funding. you do not know about that it's not your fault. t u get the drift. we do a lot together and it's significant largely ignored because people see that controversy and people we disagree on. there are plenty of those in no shortage of controversy. but there are opportunities for minority leader, example in 2111, 2012 were you able to step in and pursue keeping us from defaulting on the debt in a number of task measures.n >> at the enough, if you -- a lot of members of my party consumed by trying to cut spending and oddly enough the only time we have significantly cut spending in recentt years ws an obama was in the white house and i was minority leader. how did that happen? well, we raised the debt ceiling and there was republican majority in the house, democratic majority in the senate but in order to pass legislation that we were working on a needed 60 votes. that is how i was empowered. they needed to get 60. we ended up in a grand negotiation over reducing spending and oddly

whether it is a rule or nih's rule or the government's role, academics role, i think there is a shared expense that we need to do things differently. it doesn't mean i have a solution but having an agreement that is a problem is a start. i think there is policymaker agreements problem. >> just to add on that, i think there is also and i very much agree that there has been a shift. to try and moving a much more open and innovative approach. i think there been a couple of tools out there recently, things like the grand challenges which put out here is a problem and we need to better do this. a better way to monitor the vitals from the patient's sitting in the bully unit. it did bring in all kinds of really innovative solutions from different sources and not the usual sources that we typically look for. there are some really exciting ways to bring in those new ideas from people who aren't usually at the table. on data, i think there's also a data revolution. pushing the envelope and i am opening, openly sharing that data is not quite where we are at. it puts us closer to that place where

>> i have done some nih sponsored, in china that on one of my only experience working with the academiachina. i think if you, if we work in china with universities, we always request, we have to conform to the nih requirements on informed consent as well as human subjects, training andall that . but if it's initiated not by a collaboration with us government, then you know, those are the areas, those will be the grayareas . just a final question to any and all of you. we talk a lot about reduction which is obviously a production of pharmaceuticals and we haven't talked about devices and devices also which is critically important but also r&d is really important for the next generation of drugs, i'm thinking particularly chemotherapy. a lot of times it yourself a lot until the next one comes online and is usable. it is the us losing our leading research interests to chinese companies either operating here or chinese companies that are in china? anything you know about that? >> i can address that someone. i don't think i would go sofar as to say we are losing our leading scientists . rese

whether it's nih role or u.s. governments role or the academics role i think there is a shared sense of need to do things differently. it does not mean i have a solution but having agreement is the problem is a start and policymaker agreement is the problem. >> just to add on that, i very much agree that there's been a -- there's a shift to move in a much more innovative approach. i think there had been a couple tools out there recently like the grand challenges which put out -- here's a problem and we need a better solution or a better way to monitor the vitals from a patient is sitting in and able unit. it did bring in all kinds of really innovative solutions from different sources and not the usual so there are some exciting ways to bring in those new ideas from people who aren't at the table. on data there is also -- the data revolution and pushing the envelope on sharing that data is still not quite where we need it to be but given technologies and other approaches pushing to share data puts us in closer to t

marshall nerenberg was at nih as a scientist and so, i would say you need both models, but you do need a few institutions in each country where you are encouraging risk-taking and the long-term vision rather than this sort of turning. >> back to risk-taking, i would like to think a little bit about your own curvier path in relation to what many young people, some in the audience today who are very anxious about the competitive atmosphere and the need to publish the journal's getting the academic places and getting their first grant. you have a very long trading program and looked around for the program biology then you moved a lot several times and you even talked about utah. these are things people often discourage to take on because there's nervousness about continuing to plot out with what you have been successful in doing. how do you think that this is going to affect the progress over the next five or ten years quick >> i think that the scientists it is this hyper competitive atmosphere today that is a bad thing. people don't feel encouraged to work on these unfashionable problems

whether it's the role of nih or u.s. government control or some of the academics role, there's a shared sense that we need to do things differently. that doesn't mean i have a solution but i think having agreed that it's a problem is a start and i think there's policymaker agreement that it's a problem. >> just to add on that, i think there's also, every much agree, i think there's been a shift to try to move in a much more open source, more innovative approach. i think there's been a couple of tools of the recently things like the grand challenges which just puts outcome here's a problem, we need a better ebola suit or a better way to monitor the vitals for a patient sitting in an ebola unit. that did bring all kinds of really, really innovative solutions from different sources and not the usual sources that we typically look for. there's some really exciting ways to try to bring in those new ideas from people who are not usually at the table. and on data i think there's also, the data revolution is underway. pushing th

the nih and other public research institutions make sure we understood the health risks. i support people taking action to make sure we are banning and limiting use of pesticides. one of our biggest opportunities to address the climate crisis is to move in partnership with business and agriculture. a lot of people think that what , butns with the climate the things we're doing on the agricultural committee is doing our part. natural wildlife corridors and protect other kinds of species. the answer is science-based policy. we also want people to be locally active. california has led the way on environmental issues. we have leadership in the governor's office. i encourage you to speak up and make your voice heard and also to be healthy and safe at school. in our parks and in our public spaces. [applause] questioner: this is a about the city council. says, will you help us find a great part. our children will be listening. ,his is one of the few issues with all the problems donald trump creates, not my problem. i support a veterans cemetery. i don't think there should be any

a study by the nih found that mass shootings were reduced by 70% during that time period. there's a lot of people that argue with those statistics. they're from the national institutes of health. they were critical of the president saying he and mitch mcconnell are in bed with the gun lobby. sharrod brown also saying that at first he didn't want to go on a tour of miami valley hospital with the president because he did not want to enable the president's racist talk to which the white house is pushing back very strongly, shep, saying that it's a shame that sharrod brown is choosing politics on this solemn occasion. shep? >> shepard: john roberts live at the white house. thank you. breaking news now on fox news channel. you may have heard about the man hunt for two men accused of murdering an american woman and two others that have been on the run and in hiding in canada for weeks on end. well, now there's a break-through. it's major. and it's next. for veterans with va loans. mortgage rates are down! and you could lower your monthly payments right away by calling newday now

the answer here is i support funding that the nih and other public research institutions to make sure we understand the health risks. i support people taking action to make sure that we are banning and limiting the use of pesticides where appropriate. one of our biggest opportunities to address the climate crisis is actually to move in partnership with both business and agriculture. so a lot of people think that what happens with the climate, that it is sort of what happens with emissions that that is important. but the things we're doing on the agricultural committee are really important to addressing climate change. the things we are doing in the natural lands to create wildlife corridors, to protect different kinds of species. the answer is science-based policy. i also encourage people to be locally active. california has led the way, not just in the united states, but around the world on environment -- environmental issues. we have leadership in the governor's office that is going to continue to do that. so i encourage you to speak up, to make your voice heard we all deserve to be

if you notice, i don't know if you got the news item the head of the nih said he would no longer be on panels where there was allman. he will not go to the conferences anymore. that is something mink can do for instance. be aware that there's opposable panels bogus all dudes. people are being or attuned to that lately and this is not okay to have a culture of mail on this panel which is meant to give us a diversity of opinion and that is one way that can start to happen. there are things hr can do, this is something that can get comforted, but things that we can do to flip the equation. exercises the companies can do to say if you are the person who interrupts the most, we need to identify that and small groups and work shopping and what happens if you're the one, your role is to be the one who only test ten seconds to talk. sometimes you can run a timer on everybody at the meeting. there is a timer running and someone is talking and when it goes off you are done. and then have people come over, i guess i was talking a long time. or maybe for other participants, i don't have anything t

if you notice -- don't know it you caught this new item, the head of the nih said he would no longer be a panelist on panels where they were all men. he won't go to those conferences anymore. so that is something men can do, for instance to be aware of this -- have you heard the word manel when there are supposed panels but it's all dudes. so people are being more attuned to this, not okay to have this mono culture of male voices on a people which is meant to give a diversity of opinions. so this is one way this can start to happen. there are things hr can do. my become goes into these, get a little complicated but there are things that we can do to flip the equation. exercises the company can do to say if you're the person who talks the most, the person who interrupts the most, you identify that and we're in small groups and workshopping things here and what happens if you're the one now -- your role is to speak less than everyone else, your role is to be the one who is interested more, who only has ten seconds to talk and see what does that feel like when we flip the paradigm and s

taxpayers are not only financing research through nih but through various tax advantages.y, don't stop that. keep it going. i need new drugs, or i'm going to die. that is straight up a fact. we want it, but we want the drugs to come forward at prices we can afford. host: even before the trump administration announced its plans to work on getting lower prescription drug prices from canada, the pharmaceutical industry had already started and paying up its lobbying efforts in washington. here's a story from the fiscal times that talks about this. i will read a little to you. as congress considers legislation to lower drug prices, the pharmaceutical industry spent a record amount on lobbying in the first half of the year. ae financial times had reports based on congressional findings. the pharmaceutical research and manufacturing of america, a leading industry trade group, spent $16.1 million on lobbying in the first six month of the year, up 4% from the money is spent in the first half of 2018. million over$27.5 the full year in 2018. also a record. large drug companies put s

the head of the nih, one of the members overseeing the study and the president of georgia tech university bud peterson said wherever the study goes there must be ncaa. i believe we are addressing it. this group of esteemed panelists. we understand the potential risks and we understand some sports need to be looked at differently than other sports but we are all in this together and we will make some decisions. >> just a brief comment. the country right how is in an -- department of defense by next year in 2020, less than one in 5 high schools and will be picked for military service. we have a real problem of inactivity, of concussion, sudden cardiac death, sickle-cell -- we need to get the medical narrative right and not put fear into patients either. iq this all the time, and context and perspective, exercise is a good thing. it is an obligation to make sure the narrative is correct. i listened carefully, 6 points, not one of them was tackle football. there were other errors that led to his death because he loved the game and that is what we need to listen to to correct those problems. >

like this and the paper series, especially at a small college with hardly any travel budget is kind of nih funded projects really help out quite a bit. i want to give a plug for those because this will end up on c-span which may also be funded. so the title of this is james k. polk as war president. as commander in chief, polk oversaw a huge military effort in the mexican american war. as american soldierses invaded mexico by land and sea and one of the most successful military campaigns of the 19th century. my goal of this prev talk based on a longer essay of mine and a companion to the antibellum presidents is to access polk's performance as a war president. historians have never lacked interest in his culpability for the mexican/american war. the relevant question to me is whether polk helped or hindered the war effort with his temperament, his partisanship and his micromanagement. polk was a grand strategist who understood the good wartime leadership involves not just overseeing military operations, but also tending to domestuc krrgss considerations. polk recognized the dangers of too

the population assessment of tobacco and health study which is funded and sponsored by the fda and nihwe did find that but we also found if kids had started with the cigarette, they were 20 times more likely to continue smoking a cigarette. so the message we take from this, the use of all or any nicotine or tobacco containing products for kids will increase the risk for subsequent cigarette of smoking. the worst thing to start with would be with a combustible product like a cigarette. >> has the rate declined in smoking among adults and youth, decreased or increased since 2010 when e-cigarettes started to rise? >> we have seen steady declines in cigarette smoking both in youth and adult populations which we should take is good news. we certainly have more work to do. and yet, there is a diverging of the trends with e-cigarettes picking up in the use of cigarettes going down and that the area of active research to see whether those two things are connected with one another. >> if e-cigarettes were a gateway to smoking, what evidence show us a substantial increase in youth and adults by

my take-home salary, to nih, we made the point that we should not stop the research, and as a sample,d not really get into questions on the mom, getting into this is my son with down syndrome, and this is a pre-existing condition, because everyone, well over half of americans -- >> we are born with them. sen. klobuchar: right. yeah, exactly. but the research is very important. >> thank you. and good luck to you. sen. klobuchar: thank you. thank you so much. hi. jason: i am jason. marlene. sen. klobuchar: thank you. >> welcome to new hampshire. sen. klobuchar: i love it. everyday is like this? [laughter] >> no. sen. klobuchar: it is really great. >> thank you so much. sen. klobuchar: ok, thank you. >> thank you. best of luck. sen. klobuchar: ok thank you. ,>> it was lovely to hear you. sen. klobuchar: thank you, you are? thank you. thank you. >> that is nice. >> fabulous. >> thank you. >> can i get out of the sunlight? too.e it, sen. klobuchar: right. right back in here, right. >> that works. sen. klobuchar: at least something you know? , sure, here we go. my husband did that a lot. it

the work that is being done at nih and dr. rodgers' long standing commitment and working so closely with us on the special diabetes program has been wonderful. dr. kowalski. i think it's wonderful that jdrf now has a president and ceo who understands firsthand the challenges of type i diabetes. you have had excellent leaders in the past as well. but we are delighted to work with you. and, of course, most of all i want to thank all of the delegates here today. but especially, ruby and adriana, who are so articulate, and you are right, senator casey. i can't imagine at their ages, being able to come before a senate committee and testify and help us better understand. i also want to do a shout out to some families in maine who have really educated me on this issue. i believe that i first met ruby and her mom through the sweeney family. and i have watched their son, aidan, grow up from age four to now, he is 17. he testified at age 4. before one of the children's congress. and they are great advocates. the seer family, who have a

it's now time to support the efforts to fund nih and the cdc for gun violence prevention research. >>n this work. this is a very urgent problem. >>> still ahead, the president says he's opening gun background checks, but how long will that last now that the nra is warning him against it. plus, we'll talk to one of more than 200 mayors calling for the senate to cut its vacation short and get back to washington to address the gun violence epidemic. chicago mayor lori lightfoot joins us. "morning joe" is coming right back. us "morning joe" isom cing right back when did you see the sign? when i needed to create a better visitor experience. improve our workflow. attract new customers. that's when fastsigns recommended fleet graphics. yeah, and now business is rolling in. get started at fastsigns.com. so, every day, we put our latest technology and unrivaled network to work. the united states postal service makes more e-commerce deliveries to homes than anyone else in the country. hi. maria ramirez! mom! maria! maria ramirez... mcdonald's is committing 150 million dollars in tuition assista

something that the nih.in the same venue is another previous patient who was reexamined to ensure the treatment has been entirely successful you're like. ok so this is. the person ok when you had your diagnosis of leprosy how were your friends with you differently with a just the same. never. give him the job. you know. pagar got to move. on does that still happen or friends more understanding of the condition now i'm ok len i get. it over land. with women. do you. think if she just identified. a little area here that you can see on this young man's leg the top of it is a book on the 2nd. they. put that number. among the one. ram. on. the feeling for the nerves on the inside of the arm just by the elbow sometimes they can be 2nd with the disease these are the most typical nerves that can be affected after various noninvasive tests the team finally confirms the prac. so have we made the diagnosis and this young man. this is leprosy. treatment today starts it today. you know. within the span of. how clinician